Jorge Vélez

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 5

Top Topics

Cardiovascular Events

Top Venues

The Journal of antimicrobial chemotherapy

European heart journal. Quality of care & clinical outcomes

This page only lists publications with an associated author ORCID identifier.

Publications

Guillermo Maestro-de la Calle, Jorge Vélez, Javier Mateo Flores, Noelia García Barrio, María Ángeles Orellana, Víctor Quirós-González, Carlos Lumbreras Bermejo, José Luis Bernal
Assessment of risk-adjusted mortality ratio (RAMR) in bloodstream infections using all-patient refined diagnosis-related groups (APR-DRGs). The Journal of antimicrobial chemotherapy (2024)
Guillermo Maestro-de la Calle, Jorge Vélez, Javier Mateo Flores, Noelia García Barrio, María Ángeles Orellana, Víctor Quirós-González, Carlos Lumbreras Bermejo, José Luis Bernal
Assessment of risk-adjusted mortality ratio (RAMR) in bloodstream infections using all-patient refined diagnosis-related groups (APR-DRGs). The Journal of antimicrobial chemotherapy 79 (5) (2024)
Lourdes Vicent, Nicolás Rosillo, Jorge Vélez, Guillermo Moreno, Pablo Pérez, José Luis Bernal, Germán Seara, Rafael Salguero-Bodes, Fernando Arribas, Héctor Bueno
Profiling heart failure with preserved or mildly reduced ejection fraction by cluster analysis. European heart journal. Quality of care & clinical outcomes (2024)
Guillermo Maestro-de la Calle, Jorge Vélez, Javier Mateo Flores, Noelia García Barrio, María Ángeles Orellana, Víctor Quirós-González, Carlos Lumbreras Bermejo, José Luis Bernal
Assessment of risk-adjusted mortality ratio (RAMR) in bloodstream infections using all-patient refined diagnosis-related groups (APR-DRGs). The Journal of antimicrobial chemotherapy 79 (5) (2024)
Guillermo Maestro-de la Calle, Jorge Vélez, Javier Mateo Flores, Noelia García Barrio, María Ángeles Orellana, Víctor Quirós-González, Carlos Lumbreras Bermejo, José Luis Bernal
Assessment of risk-adjusted mortality ratio (RAMR) in bloodstream infections using all-patient refined diagnosis-related groups (APR-DRGs). The Journal of antimicrobial chemotherapy 79 (5) (2024)